Listen on the go
CORRECT!
Next question
touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES

Start Learning

Touch Loading image
JOURNALS
Start Learning
Lenacapavir achieves 100% efficacy in landmark HIV prevention trial
The Golden Gate Bridge at Sunset, San Francisco , CA
JOURNALS
Start Learning
CROI 2025: The countdown is on!
JOURNALS
Start Learning
ESCMID Global 2025 Young Investigator awardee Dr Simon Feys on ICU Medicine and Infectious Disease: touchINFECTIOUS DISEASES Future Leader 2025
JOURNALS
Start Learning
Real-world study confirms effectiveness of MVA-BN vaccine against mpox
touchIN CONVERSATION
Start Learning
Selecting ART: Working with people living with HIV to find the best regimen
Virus particles illuminated by soft, glowing light, floating in a futuristic tech-inspired blur, smooth background and strong depth of field
JOURNALS
Start Learning
Unexplained cluster of deaths investigated in the Democratic Republic of the Congo
JOURNALS
Start Learning
Q&A with ESCMID Young Investigator 2025 Dr Anthony Bai: touchINFECTIOUS DISEASES Future Leader 2025
JOURNALS
Start Learning
A warm welcome to Dr Jon Salmanton-García to our touchINFECTIOUS DISEASES Editorial Board!
CONFERENCE HUB
Start Learning
RIO phase II study reveals promise for broadly neutralising antibodies in achieving HIV remission without daily antiretroviral therapy
JOURNALS
Start Learning
Chikungunya milestone: FDA approves first vaccine for teens and adults

to view Favourites, Keep Notes and Track CME Credits

Favourites
“HIV is not over”: Rebecca Denison on 40 years of activism and survival
View
ASRA Pain Medicine release groundbreaking new surgical infection prevention guidelines
View
The start-to-finish of vaccines: Innovation and challenges at the World Vaccine Congress Europe 2024
View
RIO phase II study reveals promise for broadly neutralising antibodies in achieving HIV remission without daily antiretroviral therapy
View
The HIV vaccine race: Challenges and breakthroughs with Dr Amesika Nyaku
View
New hepatitis B guidelines released by WHO
View
Poliovirus rise in Europe: A persistent threat despite eradication efforts
View
Q&A with ESCMID Young Investigator 2025 Dr Xin Hui Chan: touchINFECTIOUS DISEASES Future Leader 2025
View
#ESCMIDGlobal2025 Insights: Key infectious disease updates clinicians shouldn’t miss
View
Vaccination strategies for pneumococcal disease: Update and perspectives on clinical need and impact
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup